MedTrace Logo

A Study in South Korea Using Medical Records to Look at Different Treatments for Chronic Obstructive Airway Disease (COPD)

NCT04172701 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 9284

Last updated 2022-04-07

Study results available
· View outcomes & findings →

Summary

Non-interventional, Single-country study based on existing data from medical records of COPD patients treated with LAMA or fixed dose combination of ICS/LABA

Conditions

  • Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

Long-acting Muscarinic Antagonists (LAMA)

drug

DRUG

Inhaled corticosteroid (ICS)/Long-acting Beta Agonists (LABA)

drug

Sponsors & Collaborators

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-15
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04172701 on ClinicalTrials.gov